KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹27 Cr | ₹15 Cr | ₹10 Cr | ₹7.37 Cr | ₹3.67 Cr |
What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹27 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹7.37 Cr |
| Mar2021 | ₹3.67 Cr |
How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹27 Cr | 82.87 | |
| Mar2024 | ₹15 Cr | 39.75 | |
| Mar2023 | ₹10 Cr | 41.82 | |
| Mar2022 | ₹7.37 Cr | 100.68 | |
| Mar2021 | ₹3.67 Cr | - | |
Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹617.4 Cr | 6.6% | -5.9% | 6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 6.6% |
-5.9% |
6.2% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses